Meltwind is a Cambridge, UK-based venture capital investor backing early-stage healthcare, biotechnology and life sciences companies across the United Kingdom, with emphasis on Series A and Series B life science tools and platform therapeutics. It manages due diligence and portfolio activity for Jonathan Milner, founder and former CEO of Abcam, and is relevant for founders in HealthTech, medical devices, pharmaceuticals and related life sciences sectors seeking venture equity.